Drug Type Antibody drug conjugate (ADC) |
Synonyms CAB-EpCAM-ADC, CAB-EрCAM, BA 3181 + [1] |
Target |
Action stimulants, inhibitors |
Mechanism CD3 stimulants(T cell surface glycoprotein CD3 stimulants), EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Phase 1 | - | - | |
| Non-Small Cell Lung Cancer | Phase 1 | - | - | |
| Ovarian Cancer | Phase 1 | - | - | |
| Prostatic Cancer | Phase 1 | - | - | |
| Small Cell Lung Cancer | Phase 1 | - | - | |
| Triple Negative Breast Cancer | Phase 1 | - | - | |
| Solid tumor | Preclinical | United States | - |






